Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2240| Title: | 30-day valve in valve transcatheter aortic valve implantation outcomes, from ACE-TAVI registry. |
| Epworth Authors: | Haji, Kawa Nanayakkara, Shane Palmer, Sonny Noaman, Samer Dick, Ronald Walton, Antony |
| Other Authors: | Zimmet, Adam McGaw, David Reid, J Johnston, Rox Htun, Nay Min Stub, Dion |
| Keywords: | Valve in Valve Transcatheter Aortic Valve Implantation VIV TAVI Bioprosthetic Valve Failure Australia Clinical Outcome ACE-TAVI Registry Cardiac Sciences Clinical Institute |
| Issue Date: | Oct-2023 |
| Conference Name: | Epworth HealthCare Research Month 2023 |
| Conference Location: | Epworth Research Institute, Victoria, Australia |
| Abstract: | There is an increasing number of surgical and transcatheter bioprosthetic valve implantations which after a few years eventually fail. Analysis of data was undertaken from ACE-TAVI registry, a prospective TAVI registry that incudes 3 major hospitals in Melbourne, Victoria. All patients who underwent VIV TAVI from 2008 to 2022 were included. Data from a large Australian multicentre registry shows that similar to overseas, VIV TAVI is a safe procedure with excellent outcomes and favourable survival at 30 days |
| URI: | http://hdl.handle.net/11434/2240 |
| Type: | Conference Poster |
| Affiliated Organisations: | Alfred Health, Department of Cardiology, Melbourne, Victoria, Australia. Cabrini, Malvern, Victoria, Australia |
| Type of Clinical Study or Trial: | Retrospective studies |
| Appears in Collections: | Research Week |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Valve in Valve_Kawa Haji.pdf | 427.31 kB | Adobe PDF |  View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.